Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.
Marc G. Caron(Howard Hughes Medical Institute), Fernand Labrie(Endocyte (United States)), Jacques Drouin(Montreal Clinical Research Institute), Robert J. Lefkowitz(Howard Hughes Medical Institute), Bernard Gagné(Medical Council of Canada), Jean‐Martin Beaulieu(University of Toronto), Vincent Raymond(Medical Council of Canada)
Cited by 383
Related Papers
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
|Pharmacological Reviews|2011|2.7k
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
|Cell|2005|966
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
|Annual Review of Neuroscience|2004|859
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
|Proceedings of the National Academy of Sciences|2004|786
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
|Journal of Biological Chemistry|2005|756